Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: New perspectives on promoting heart health

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 5, 2013, Pages 1547-1557

  Sih, Juliana ^a   Bansal, Shyam S ^a   Filipini, Stefano ^a   Ferrati, Silvia ^a   Raghuwansi, Kunal ^b   Zabre, Erika ^a   Nicolov, Eugenia ^a   Fine, Daniel ^a   Ferrari, Mauro ^a,c,d,e   Palapattu, Ganesh ^f   Grattoni, Alessandro ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b NanoMedical Systems Inc   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Rice University   (United States)

^e Alliance for NanoHealth   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardioprotection; Drug delivery; Implants; Nanochannel membranes; Sustained release

Indexed keywords

ACETONE; CONTROLLED DRUG DELIVERY; DENTAL PROSTHESES; DIELECTRIC MATERIALS; DRUG DELIVERY; DRUG PRODUCTS; ENDOTHELIAL CELLS; FLOW OF GASES; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MEMBRANES; MORPHOLOGY; RESVERATROL; SCANNING ELECTRON MICROSCOPY; SILICA; SILICON NITRIDE; SILICON OXIDES;

CARDIOPROTECTION; DRUG DELIVERY SYSTEM; HUMAN MICROVASCULAR ENDOTHELIAL CELLS; INDUSTRIAL FABRICATION; NANO CHANNELS; SCANNING AND TRANSMISSION ELECTRON MICROSCOPY; SURFACE CHARGE ANALYSIS; SUSTAINED RELEASE;

TARGETED DRUG DELIVERY;

EID: 84873705764     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6484-7     Document Type: Article

References (44)

1. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC (2011) Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res (Phila) 4(8):1158-1171. doi: 10.1158/1940-6207.CAPR-10-0006
2. Grattoni A, Shen H, Fine D, Ziemys A, Gill JS, Hudson L, Hosali S, Goodall R, Liu X, Ferrari M (2011) Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration. Pharm Res 28(2):292-300. doi: 10.1007/s11095-010-0195-6
3. Cohen JD, Brinton EA, Ito MK, Jacobson TA (2012) Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol 6(3):208-215. doi: 10.1016/j.jacl.2012.03.003
4. Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan L, Pant R, Menon VP, Otani H, Maulik N (2007) Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 42(3):508-516. doi: 10.1016/j.yjmcc.2006.10.018
5. Palem CR, Patel S, Pokharkar VB (2009) Solubility and stability enhancement of atorvastatin by cyclodextrin complexation. PDA j pharm sci technol/PDA 63(3):217-225
6. Toth PP, Thakker KM, Jiang P, Padley RJ (2012) Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy. Vasc Health Risk Manag 8:39-44. doi: 10.2147/VHRM.S22601
7. Neves AR, Lucio M, Lima JL, Reis S (2012) Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 19(11):1663-1681
8. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK (2002) Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 282(6):H1996-H2003. doi: 10.1152/ajpheart.01013.2001
9. Kaga S, Zhan L, Altaf E, Maulik N (2006) Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol 40(1):138-147. doi: 10.1016/j.yjmcc.2005.09.009
10. Amri A, Chaumeil JC, Sfar S, Charrueau C (2012) Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158(2):182-193. doi: 10.1016/j.jconrel.2011.09.083
11. Fine D, Grattoni A, Hosali S, Ziemys A, De Rosa E, Gill J, Medema R, Hudson L, Kojic M, Milosevic M, Brousseau Iii L, Goodall R, Ferrari M, Liu X (2010) A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery. Lab Chip 10(22):3074-3083. doi: 10.1039/c0lc00013b
12. Grattoni A, Rosa ED, Ferrati S, Wang Z, Gianesini A, Liu X, Hussain F, Goodall R, Ferrari M (2009) Analysis of a nanochanneled membrane structure through convective gas flow. J Micromech Microeng 19(11):115018
13. Laerme F, Schilp A, Funk K, Offenberg M (1999) Bosch deep silicon etching: improving uniformity and etch rate for advanced MEMS applications. In: Micro Electro Mechanical Systems, 1999. MEMS '99. Twelfth IEEE International Conference on, 17-21 Jan 1999. pp 211-216. doi: 10.1109/memsys.1999.746812
14. Grattoni A, Fine D, Zabre E, Ziemys A, Gill J, Mackeyev Y, Cheney MA, Danila DC, Hosali S, Wilson LJ, Hussain F, Ferrari M (2011) Gated and near-surface diffusion of charged fullerenes in nanochannels. ACS Nano 5(12):9382-9391. doi: 10.1021/nn2037863
15. Doppers LM, Sammon C, Breen C, Yarwood J (2006) FTIR-ATR studies of the sorption and diffusion of acetone/water mixtures in poly(vinyl alcohol). Polymer 47:2714-2722
16. database g-c (2010) GSI Environment Inc, USA http://www.gsi-net.com/en/ publications/gsi-chemical-database/single/4.html. Accessed June 12, 2012
17. Karniadakis G, Beskok A, Aluru NR (2005) Microflows and nanoflows: fundamentals and simulation. Springer, New York
18. Hamblin MN, Edwards JM, Lee ML, Woolley AT, Hawkins AR (2007) Electroosmotic flow in vapor deposited silicon dioxide and nitride microchannels. Biomicrofluidics 1(3):34101. doi: 10.1063/1.2752376
19. Firnkes M, Pedone D, Knezevic J, Doblinger M, Rant U (2010) Electrically facilitated translocations of proteins through silicon nitride nanopores: conjoint and competitive action of diffusion, electrophoresis, and electroosmosis. Nano Lett 10(6):2162-2167. doi: 10.1021/nl100861c
20. Datta S, Conlisk AT, Kanani DM, Zydney AL, Fissell WH, Roy S (2010) Characterizing the surface charge of synthetic nanomembranes by the streaming potential method. J Colloid Interface Sci 348(1):85-95. doi: 10.1016/j.jcis.2010.04.017
21. Pitt CG, Gratzl MM, Jeffcoat AR, Zweidinger R, Schindler A (1979) Sustained drug delivery systems II: factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. J Pharm Sci 68(12):1534-1538
22. Bansal SS, Kausar H, Vadhanam MV, Ravoori S, Gupta RC (2012) Controlled systemic delivery by polymeric implants enhances tissue and plasma curcumin levels compared with oral administration. Eur J Pharm Biopharm 80(3):571-577. doi: 10.1016/j.ejpb.2011.12.009
23. Tamada J, Langer R (1992) The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Ed 3(4):315-353
24. Lemmouchi Y, Schacht E, Lootens C (1998) In vitro release of trypanocidal drugs from biodegradable implants based on poly([var epsilon]-caprolactone) and poly(-lactide). J Control Release 55(1):79-85. doi: 10.1016/s0168-3659(98) 00021-2
25. Bansal SS, Vadhanam MV, Gupta RC (2011) Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin. Pharm Res 28(5):1121-1130. doi: 10.1007/s11095-011-0375-z
26. Ron E, Turek T, Mathiowitz E, Chasin M, Hageman M, Langer R (1993) Controlled release of polypeptides from polyanhydrides. Proc Natl Acad Sci U S A 90(9):4176-4180
27. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444(7117):337-342. doi: 10.1038/nature05354
28. Lennernas H (2003) Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet 42:1141-1160
29. Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci 1215:9-15. doi: 10.1111/j.1749-6632.2010.05842.x
30. Hung CF, Chen JK, Liao MH, Lo HM, Fang JY (2007) The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion. Int J Pharm 335:193-202
31. Hung CF, Chen JK, Liao MH, Lo HM, Fang JY (2006) Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol 6:2950-2958
32. Adah F, Benghuzzi H, Tucci M, Russell G, England B (2006) Effects of sustained release of statin by means of tricalcium phosphate lysine delivery system in defect and segmental femoral injuries on certain biochemical markers in vivo. Biomed Sci Instrum 42:126-135
33. Laurencin C, Domb A, Morris C, Brown V, Chasin M, McConnell R, Lange N, Langer R (1990) Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. J Biomed Mater Res 24(11):1463-1481. doi: 10.1002/jbm.820241105
34. Bansal SS, Kausar H, Aqil F, Jeyabalan J, Vadhanam MV, Gupta RC, Ravoori S (2011) Curcumin implants for continuous systemic delivery: safety and biocompatibility. Drug Deliv Trans Res 1:332-341
35. Weisenberg BA, Mooradian DL (2002) Hemocompatibility of materials used in microelectromechanical systems: platelet adhesion and morphology in vitro. J Biomed Mater Res 60(2):283-291
36. Baier RE, DePalma VA, Goupil DW, Cohen E (1985) Human platelet spreading on substrata of known surface chemistry. J Biomed Mater Res 19(9):1157-1167. doi: 10.1002/jbm.820190922
37. Bogner E, Dominizi K, Hagl P, Bertagnolli E, Wirth M, Gabor F, Brezna W, Wanzenboeck HD (2006) Bridging the gap - biocompatibility of microelectronic materials. Acta biomaterialia 2(2):229-237. doi: 10.1016/j.actbio.2005.10.006
38. Cappi B, Neuss S, Salber J, Telle R, Knuchel R, Fischer H (2010) Cytocompatibility of high strength non-oxide ceramics. J Biomed Mater Res A 93(1):67-76. doi: 10.1002/jbm.a.32527
39. Kotzar G, Freas M, Abel P, Fleischman A, Roy S, Zorman C, Moran JM, Melzak J (2002) Evaluation of MEMS materials of construction for implantable medical devices. Biomaterials 23(13):2737-2750
40. Neumann A, Reske T, Held M, Jahnke K, Ragoss C, Maier HR (2004) Comparative investigation of the biocompatibility of various silicon nitride ceramic qualities in vitro. J Mater Sci Mater Med 15(10):1135-1140. doi: 10.1023/B:JMSM.0000046396.14073.92
41. Voskerician G, Shive MS, Shawgo RS, von Recum H, Anderson JM, Cima MJ, Langer R (2003) Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 24(11):1959-1967
42. Chemical Database, Chemicalize (2012) ChemAxon http://www.chemicalize. org/structure/#!mol=lipitor. Accessed June 12, 2012
43. Chemical Database, ChemSpider (2012) RSC, Cambridge, http://www. chemspider.com/Chemical-Structure.54810. Accessed June 12, 2012
44. Filip V, Plocková M, Šmidrkal J, Špič ková Z, Melzoch K, Schmidt Š (2003) Resveratrol and its antioxidant and antimicrobial effectiveness. Food Chem 83(4):585-593. doi: 10.1016/s0308-8146(03)00157-2